lorlatinib
Drug timelines are a Plus or Pro feature.
22 regulatory and trial events tracked for lorlatinib, covering 2016-05-17 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases [Phase 4]